StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note released on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Up 3.4 %
Shares of NASDAQ:AEZS opened at $4.00 on Thursday. The company has a market cap of $7.17 million, a PE ratio of -0.26 and a beta of 1.55. Aeterna Zentaris has a fifty-two week low of $3.96 and a fifty-two week high of $12.00. The firm has a 50-day simple moving average of $5.44 and a 200 day simple moving average of $6.95.
About Aeterna Zentaris
Further Reading
- Five stocks we like better than Aeterna Zentaris
- Using the MarketBeat Stock Split Calculator
- Emerging Markets: What They Are and Why They Matter
- What is the Euro STOXX 50 Index?
- Recession or Not, These 3 Stocks Are Winners
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Why NVIDIA Is More of a Screaming Buy Than Ever
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.